Clinical Trials Directory

Trials / Completed

CompletedNCT00280384

An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian Subjects

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Eisai Limited · Industry
Sex
Male
Age
20 Years – 44 Years
Healthy volunteers
Not accepted

Summary

To evaluate inter-ethnic similarity in pharmacodynamics between Japanese and Caucasian healthy adult male subjects by comparing electrophysiological reactions after administering E2014 to extensor digitorum brevis muscle (EDB).

Conditions

Interventions

TypeNameDescription
DRUGE2014 (Botulinum toxin type B)A single-dose injection solution containing 20 units (U), 100 U, or 500 U/ 0.2 milliliters (mL) of E2014 was administered to extensor digitorum brevis (EDB) muscle in the left lower limb to Japanese and Caucasian participants. Duration of treatment lasted for 12 weeks: from Day -1 to Week 12. Participants were hospitalized from a day before study treatment to Day 8 for 9 nights and 10 days, and visited at the medical institution on Days 10 and 14, and Weeks 4 and 12.
DRUGE2014 (Botulinum toxin type B) PlaceboA single-dose injection solution of E2014 Placebo was administered to extensor digitorum brevis (EDB) muscle in the left lower limb to Japanese and Caucasian participants. Duration of treatment lasted for 12 weeks: from Day -1 to Week 12. Participants were hospitalized from a day before study treatment to Day 8 for 9 nights and 10 days, and visited at the medical institution on Days 10 and 14, and Weeks 4 and 12.

Timeline

Start date
2006-01-01
Primary completion
2006-08-01
First posted
2006-01-23
Last updated
2013-04-25
Results posted
2013-04-25

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00280384. Inclusion in this directory is not an endorsement.